TrialCancer prevention research (Philadelphia, Pa.)2011

Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics.

Lynne M Howells et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.